| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.31 | 1e-09 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.27 | 9e-07 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.26 | 2e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.25 | 3e-06 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |